Revised: 26 August 2026
Medicines
Medsafe Product Detail |
||
|---|---|---|
| File ref: TT50-7970/1 |
| Trade Name | Dose Form | Strength | Identifier |
|---|---|---|---|
| Panvax vaccine | Suspension for injection | 30 mcg/0.5mL | Pandemic Influenza vaccine |
| Sponsor | Application date | Regulatory status | Classification |
| Seqirus (NZ) Ltd P O Box 62590 Greenlane Auckland 1546 |
16/08/2010 | Provisional consent Approval date:6/03/2014 Expiry date:6/03/2028 Notification date: 5/03/2020 |
Prescription |
Provisional consent under section 23 of the Medicines Act 1981 is given with the following condition:
The vaccine may only be marketed or distributed in accordance with the directives contained in the current version of the New Zealand Influenza Pandemic Action Plan.
Composition
| Component | Ingredient | Manufacturer |
|---|---|---|
| suspension for injection | Active | |
| Influenza Virus Type A haemagglutinin 30ug (Pandemic influenza virus haemagglutinin) | Seqirus Pty Ltd 39-79 Poplar Road Parkville Victoria 3052 AUSTRALIA | |
| Excipient | ||
| Aluminium as aluminium phosphate adjuvant | ||
| Calcium chloride | ||
| Dibasic sodium phosphate | ||
| Monobasic potassium phosphate | ||
| Monobasic sodium phosphate | ||
| Potassium chloride | ||
| Sodium chloride | ||
| Thiomersal | ||
| Water for injection |
Production
| Manufacturing step | Manufacturer |
|---|---|
| Finished Product Testing | Seqirus Pty Ltd 39-79 Poplar Road Parkville Victoria 3052 AUSTRALIA |
| Finished Product Testing - Microbiological | CSL Behring (Australia) Pty Ltd 189-209 Camp Road, Broadmeadows VIC 3047 AUSTRALIA |
| Manufacture of Active Ingredient | Seqirus Pty Ltd 39-79 Poplar Road Parkville Victoria 3052 AUSTRALIA |
| Manufacture of Final Dose Form | Seqirus Pty Ltd 39-79 Poplar Road Parkville Victoria 3052 AUSTRALIA |
| Secondary Packaging | CSL Behring (Australia) Pty Ltd 189-209 Camp Road, Broadmeadows VIC 3047 AUSTRALIA |
| Seqirus Pty Ltd 39-79 Poplar Road Parkville Victoria 3052 AUSTRALIA | |
| NZ Site of Product Release | Seqirus (NZ) Ltd Level 3 60 Parnell Road Parnell AUCKLAND 1052 |
Packaging
| Package | Contents | Shelf life |
|---|---|---|
| Vial, glass, multi-dose, 50 vials per pack | 1000 dose units | 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) protect from light |
Indications
Prophylaxis of influenza in an officially declared pandemic situation. The vaccine may only be marketed or distributed in accordance with the directive contained in the current version of the New Zealand Influenza Pandemic Action Plan.
Latest Regulatory Activity
| Application Date | Application Type | Change(s) | Status | Payment Date | Priority |
|---|---|---|---|---|---|
| 16/08/2010 | Provisional Consent (Section 23) | New medicine - provisional consent | Granted | 18/08/2010 | |
| 15/01/2013 | Provisional Consent (Section 23) | New medicine - provisional consent | Granted | 25/01/2013 | |
| 5/11/2025 | Provisional Renewal | Renewal of provisional consent | Granted | 16/12/2025 |
